Search Results 1361-1370 of 19444 for Hemoglobin

1. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies - Mayo Clinic

   * Hemoglobin ≥ 9.0 g/dL (Part 1) * Absolute neutrophil count (ANC) ≥ 1,500/dL (Part 1) * Platelet count ≥100,000/μL (Part 1) or ≥75,000/μL (Part 3)

2. Dasatinib (oral route) - Side effects & dosage - Mayo Clinic

   It is also used to treat Ph+ CML and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in adults after other medicines (eg, imatinib) or ...

3. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

   Confused by all the treatment choices for type 2 diabetes? Use this guide to better understand the medicines available to help control blood sugar.

4. Pilot Study Of Duodenal Mucosal RF Vapor Ablation In US Subjects With Type-2 Diabetes Mellitus - Mayo Clinic

   Persistent anemia, defined as hemoglobin <10g/dl. Significant cardiovascular disease, including known history of valvular disease, or myocardial infarction ...

5. Immune globulin (intramuscular route, intravenous route, subcutaneous route) - Side effects & uses - Mayo Clinic

   It is used for patients who have idiopathic thrombocytopenic purpura (ITP), chronic immune thrombocytopenic purpura, chronic inflammatory demyelinating ...

6. High white blood cell count Causes - Mayo Clinic

   In general, for adults a count of more than 11,000 white blood cells in a microliter of blood is considered high. A test a health care provider orders to ...

7. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable). Creatinine clearance (CrCL) ...

8. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Creatinine ≤ 2 x ULN; SGOT (AST) ≤ 2 x ULN; Albumin ≥ 3 g/dL. Willing and able to provide research stool and blood samples. Negative ...

9. A Study to Evaluate UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; or ≥ 5.6 mmol/L. Renal. Creatinine ≤ 1.5 x upper limit of normal (ULN). Hepatic. Total bilirubin ≤1.5 x ULN; or; Direct bilirubin ...

10. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

    Hemoglobin (Hgb) ≥ 90 g/L,; Platelets (plt) ≥ 100 x 109/L,; Potassium within normal range, or correctable with supplements,; Aspartate Aminotransferase (AST) ...